Call Us
Understanding Polycythemia Vera - Causes, Symptoms and Treatment

Understanding Polycythemia Vera - Causes, Symptoms and Treatment

title image

Dr. Vrundali Kannoth5 minutes31 Dec 2025

Polycythemia Vera Overview: Causes, Symptoms and Treatment

Have you been having persistent headaches for months? Is your face looking unusually red, and fatigue won't lift despite good sleep? Is your blood work showing alarmingly high red blood cell counts?

After more tests, you hear an unfamiliar diagnosis - polycythemia vera.

You wonder:

What does this mean? How serious is it? The doctor mentions it's a rare blood disorder, not a typical cancer, but requires lifelong management.

In this guide

we explain polycythemia rubra vera, its symptoms, diagnosis process, and treatment, helping you understand what you're facing and what comes next.

What is polycythemia vera?

Polycythemia vera is a rare, chronic blood disorder in which bone marrow produces too many red blood cells. This overproduction thickens blood, slowing flow through vessels and increasing risks of dangerous clots.

Polycythemia vera meaning breaks down as: "poly" (many), "cyt" (cells), "hemia" (blood), "vera" (true) - literally "true excess of blood cells."

Polycythemia vera is classified among myeloproliferative neoplasms - a group of bone marrow diseases involving excessive cell production.

Understanding is polycythemia vera cancer is important: polycythemia vera is not cancer in the traditional sense, though it requires similar vigilant monitoring.

Who is affected by polycythemia vera?

This disorder typically affects adults over 60, though it can occur at any age. Men develop it slightly more often than women. Global estimates suggest 2-3 cases per 1,00,000 people annually.

The disease progresses slowly. Many people live for decades with proper management and regular monitoring by oncology doctors or haematologists.

How polycythemia vera affects the body

Excess red blood cells thicken the blood consistency, making it flow sluggishly through vessels. This creates multiple problems: organs receive less oxygen despite high counts, dangerous blood clots form more easily, and the spleen enlarges from filtering extra cells.

Thickened blood raises risks for heart attack, stroke, and cardiovascular events. Without treatment, these complications threaten life.

Symptoms and causes

Recognising symptoms enables early detection, while understanding causes provides context for this disorder's development.

Polycythemia vera symptoms help doctors identify the condition early.

Polycythemia vera symptoms

The condition's symptoms vary widely; some people experience no initial symptoms.

Core symptoms:

  • Fatigue
    Despite high red blood cell counts, cancer fatigue affects most patients due to poor oxygen delivery.
  • Headaches
    Frequent, persistent headaches result from thickened blood and reduced brain circulation.
  • Dizziness
    Poor circulation affects balance and causes vertigo.
  • Vision problems
    Blurred vision occurs due to circulation issues.
  • Itching after warm baths
    This unique symptom (aquagenic pruritus) affects many patients.
  • Red facial appearance
    Excess red blood cells create a ruddy, flushed complexion.
  • Enlarged spleen
    The spleen enlarges (splenomegaly), causing left upper abdominal discomfort.
  • Digestive issues
    Some patients experience nausea and acid reflux, though these are less specific.

Early signs:

Early stages of polycythemia vera often produce subtle symptoms: mild fatigue, occasional headaches, slightly flushed skin. Many attribute these to ageing rather than disease.

Advanced symptoms:

As the disease progresses, symptoms intensify with severe itching, marked splenomegaly, and frequent headaches.

Polycythemia vera causes

The condition involves genetic mutations rather than inherited factors. Polycythemia vera causes include JAK2 gene mutation (specifically JAK2 V617F), which signals bone marrow to overproduce blood cells.

This mutation isn't inherited, and it develops during life (acquired mutation). Why it occurs remains unknown. It's not linked to environmental exposures or preventable risks.

Types, classification and stages

Understanding disease classification helps doctors plan treatment strategies effectively.

Types of polycythemia (primary and secondary)

Polycythemia vera types fall into broader polycythemia categories:

  • Primary:
    The bone marrow disorder we're discussing - intrinsic overproduction.
  • Secondary:
    Develops in response to other conditions (lung disease, sleep apnea, kidney tumours, high altitude). Treatment focuses on underlying causes.

Distinguishing between types is crucial because treatments differ significantly.

Classification of polycythemia vera

Polycythemia vera classification uses the WHO system, considering genetic mutations, blood counts, and bone marrow characteristics to confirm diagnosis and guide treatment.

Disease progression stages

Stages of polycythemia vera describe progression:

  • Early stage
    Mild symptoms, slightly elevated counts, minimal organ involvement.
  • Progressive stage
    Counts rise further, the spleen enlarges, and symptoms worsen. Polycythemia vera progression becomes evident through increasing complications.
  • Advanced stage
    Significant organ involvement, marked splenomegaly, high complication risks. Some develop post polycythemia vera conditions.

Risks, complications and long- term outlook

While manageable, this disorder carries serious risks requiring vigilant monitoring.

Common complications of polycythemia vera

Polycythemia vera complications include:

  • Thrombosis
    Clots represent the most serious risk, causing heart attack, stroke, or pulmonary hypertension.
  • Bleeding
    Despite thick blood, paradoxical bleeding occurs from impaired platelet function.
  • Enlarged spleen
    Progressive splenomegaly causes discomfort.
  • Digestive problems
    Increased risk of peptic ulcer disease occurs. Patients wonder can stomach ulcers cause cancer , but while ulcers don't directly cause malignancy, managing digestive health remains important.
  • Gout
    High uric acid from increased cell turnover causes painful joints.

Leukaemia transformation risk

Polycythemia vera clinical features include a small risk of transformation to acute myeloid leukaemia, occurring in 2-10% of patients depending on treatment and disease duration.

Post-polycythemia vera conditions

The disease can evolve into myelofibrosis, where bone marrow develops scar tissue. This occurs in 10-20% of patients over time.

Polycythemia vera life expectancy & survival rate

Prognosis has improved dramatically. Polycythemia vera life expectancy with proper management allows many to live 10-20+ years after diagnosis. However, the polycythemia vera survival rate depends on age, treatment adherence, and complications.

Diagnosis and tests

Accurate polycythemia vera diagnosis requires multiple tests to confirm the disease and rule out secondary causes.

How polycythemia vera is diagnosed

Polycythemia vera workup begins when routine blood tests show elevated red blood cells. Doctors investigate whether this represents a true disease or secondary causes.

Polycythemia vera criteria (WHO diagnostic criteria) include elevated haemoglobin/hematocrit, bone marrow changes, and JAK2 mutation presence.

Tests for polycythemia vera

Polycythemia vera test options include:

  • Complete Blood Count (CBC)
    Measures all blood cell types, showing elevated red cells.
  • JAK2 mutation test
    Genetic test detecting the mutation present in 95% of cases.
  • Erythropoietin (EPO) levels
    Measures hormone stimulating red cell production. Levels are typically low.
  • Bone marrow biopsy
    Examines marrow cells directly.
  • Additional tests
    Include ferritin, vitamin B12, oxygen saturation, and an ultrasound for spleen size.

Treatment and management

Polycythemia vera treatment aims to reduce blood thickness and prevent complications.

  • Phlebotomy
    Primary treatment - regular blood removal reduces red cell volume. Performed every few weeks initially, then adjusted based on blood counts. The procedure is similar to blood donation and typically takes 30-45 minutes.
  • Low-dose aspirin
    Reduces clot risk. Most patients take 75-100mg daily unless contraindicated by bleeding history.
  • Hydroxyurea
    Medication reducing blood cell production for high-risk patients over 60 or those with previous clots. Taken orally once daily. There are newer drugs like Jakafi/Ropeginterferon as well.
  • Interferon alfa
    Alternative for younger patients or pregnancy when hydroxyurea is contraindicated. Administered via injection.
  • Ruxolitinib
    JAK2 inhibitor for patients not responding to or tolerating hydroxyurea. Effectively reduces spleen size and symptom burden.
  • Symptom management
    Antihistamines help control itching. Allopurinol prevents gout by lowering uric acid levels.

Polycythemia vera treatment cost in India varies between ₹1 lakh and ₹12 lakhs based on the method, hospital and several other factors.

Regular monitoring ensures optimal control and early complication detection. Working with haematologists provides comprehensive cancer treatment-level care.

Conclusion

This rare blood disorder results from the overproduction of red blood cells in the bone marrow due to JAK2 mutations, leading to blood thickening and an increased risk of clotting.

While many ask about blood cancer connections, polycythemia rubra vera (an older name for the condition) represents a chronic myeloproliferative disorder requiring lifelong management rather than typical cancer care.

Polycythemia vera cure remains elusive, as current treatments manage rather than eliminate the disorder, but proper care allows most patients to maintain a good quality of life.

The long-term outlook has improved significantly due to a better understanding of the disease. Regular monitoring for cancer symptoms and complications ensures prompt intervention, while awareness of transformation risks guides treatment decisions.

If you've been diagnosed or suspect you might have this condition based on symptoms, working with specialised haematologists provides the best outcomes for managing this complex types of cancer -related blood disorder.

FAQs

No, though it's classified as a myeloproliferative neoplasm - a chronic blood disorder involving abnormal cell growth. Unlike typical cancers that spread to other organs, it stays within the blood and bone marrow. However, it requires similar vigilant monitoring.

It's another name for the same condition. "Rubra" means red in Latin, referring to the characteristic redness from excess red blood cells. Modern medicine generally uses just the shorter name, though you may see the longer version in older literature.

No, it's not currently curable, but highly manageable. Treatments control blood cell production and prevent complications, allowing most patients to live long, relatively normal lives. Research continues into targeted therapies that might eventually cure it by correcting the underlying genetic mutation.

Related Blogs

View More
Understanding Polycythemia Vera - Causes, Symptoms and Treatment